Observational studyDiabetes, obesity & metabolism2021

Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

Kåre I Birkeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.